Question 1

Does JPMorgan Chase own TXG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 753,045 shares of TXG (10x Genomics), worth $28.2M.

Question 2

How many shares of TXG does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 753,045 shares of TXG (10x Genomics).

Question 3

What is JPMorgan Chase's TXG position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's TXG position is worth $28.2M.

Question 4

Is JPMorgan Chase buying or selling TXG?

Accepted Answer

In Q2 2026, JPMorgan Chase reduced its TXG position by 32,460 shares (-4.1%).

Question 5

When did JPMorgan Chase first buy TXG?

Accepted Answer

JPMorgan Chase already held TXG in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	753,045	-4.1%	$28.2M	0.0%	$38.34	0
2026-Q1	Decreased	785,505	-15.4%	$15.6M	0.0%	$21.23	0
2025-Q4	Decreased	928,426	-13.5%	$15.1M	0.0%	$16.31	0
2025-Q3	Increased	1.1M	+777.6%	$12.6M	0.0%	$11.69	45
2025-Q2	Decreased	122,370	-39.7%	$1.4M	0.0%	$11.58	0
2025-Q1	Decreased	202,890	-31.7%	$1.8M	0.0%	$8.73	0
2024-Q4	Decreased	296,902	-16.5%	$4.3M	0.0%	$14.36	0
2024-Q3	First report	355,488	—	$8M	0.0%	$22.58	0